Pharmacological prevention of coronary thrombosis
Spławińska, B.; Spławiński, J.
Polski Tygodnik Lekarski 42(26): 795-801
1987
ISSN/ISBN: 0032-3756 PMID: 3313320 Document Number: 293959
Document emailed within 1 workday
Related Documents
Hansen, M.S.; Birgens, H.S. 1980: Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification Ugeskrift for Laeger 142(5): 303-305Bucha, E.; Nowak, G.; Markwardt, F. 1988: Prevention of experimental coronary thrombosis by hirudin Folia Haematologica 115(1-2): 52-58
Jackson, C.V.; Crowe, V.G.; Frank, J.D.; Wilson, H.C.; Coffman, W.J.; Utterback, B.G.; Jakubowski, J.A.; Smith, G.F. 1992: Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis Journal of Pharmacology and Experimental Therapeutics 261(2): 546-552
Kocemba, J.; Kawecka-Jaszcz, K.; Magdoń, M. 1981: The effect of six years lasting primary non pharmacological prevention of coronary heart disease on hypercholesterolemia in occupationally working men Przeglad Lekarski 38(12): 857-860
Uzan, A.; Clairefond, P.; Mardiguian, J.; Trillou, M.; Le Fur, G.; Mestre, M. 1985: Prevention of experimental thrombosis of the coronary artery, in anesthetized dogs, with a low molecular weight heparin, enoxaparine (PK 10169) Annales Pharmaceutiques Francaises 43(6): 539-546
Goracy, J.ła.; Lewandowski, M.; Kossuth, I. 2007: Myocardial infarction and left coronary thrombosis with atypical coronary angiogram Kardiologia Polska 65(4): 451
Böttger, W.; Güthert, H.; Vollmar, F.; Müller, L. 1976: Coronary atherosclerosis, coronary thrombosis and myocardial infarction in autopsy cases Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 120(6): 487-499
Vollmar, F.; Güthert, H. 1971: Coronary sclerosis and its sequelae (Statistical studies on unselected autopsy material) . 3. Coronary thrombosis Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 26(16): 515-519
Berns, S.A.; Shmidt, E.A.; Kiprina, E.S.; Barbarash, O.L.; Veremeev, A.V.; Gruzdeva, O.V.; Moiseenkov, G.V. 2011: Predictors of stent thrombosis in patients with ST-elevation acute coronary syndrome subjected to primary coronary artery intervention Kardiologiia 51(4): 10-15
Manganaro, A.; Giannino, D.; Lembo, D.; Bruni, F.; Consolo, F. 2000: Evolution in the pharmacological treatment of venous thrombosis according to evidence-based medicine Minerva Cardioangiologica 48(12 Suppl 1: 41-51
Bazaugour, R.; Evreux, J.C.; Evrard, J.P. 1972: Coronary vasodilators: pharmacological aspect Lyon Medical 228(17): 427-433
Bosc, E.; Causse, M.; Navarro, N.; Grolleau, R.; Souchon, H. 1979: Coronary thrombosis during polycythemia Annales de Cardiologie et d'Angeiologie 28(3): 155-161
Goto, S. 2016: Platelets in coronary thrombosis Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl 4 Pt 1: 118-124
Brzostek, T. 2003: Pharmacological treatment in patients undergoing coronary angioplasty Kardiologia Polska 59(11): 457-460
Looi, K.L.; Chow, K.L.; Looi, J.L.; Lee, M.; Halliday, S.; White, H.; Ellis, C. 2011: Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery New Zealand Medical Journal 124(1343): 18-27
Swan, H.J. 1989: Thrombosis in the acute coronary syndromes Indian Heart Journal 41(4): 210-212
Werkö, L. 1974: Coronary thrombosis and heart infarct Lakartidningen 71(48): 4920-4923
Rasmussen, K.B.; Pilgaard, J. 1995: Arteritis as the cause of fatal coronary thrombosis Ugeskrift for Laeger 157(16): 2324-2325
Simoons, M.L.; Vos, J.; Deckers, J.W.; de Feyter, P.J. 1995: Coronary artery disease: prevention of progression and prevention of events European Heart Journal 16(6): 729-733
Duckles, S.P. 1988: Vascular muscarinic receptors: pharmacological characterization in the bovine coronary artery Journal of Pharmacology and Experimental Therapeutics 246(3): 929-934